1 |
2022 |
Georg Bauer, Friedhelm Struck, Eva Staschik, Julia Maile, Karin Wochinz‐Richter, Manfred Motz, Erwin Soutschek. Differential avidity determination of IgG directed towards the receptor‐binding domain (RBD) of SARS‐CoV‐2 wild‐type and its variants in one assay: Rational tool for the assessment of protective immunity, Journal of Medical Virology. 2022; 94: 5294.
https://doi.org/10.1002/jmv.28006 |
2 |
2024 |
Oladayo A. Oyebanji, Nicholas Sundheimer, Vaishnavi Ragavapuram, Brigid M. Wilson, Yasin Abul, Stefan Gravenstein, Jürgen Bosch, Christopher L. King, David H. Canaday. Avidity maturation of humoral response following primary and booster doses of BNT162b2 mRNA vaccine among nursing home residents and healthcare workers, GeroScience. 2024; 46: 6183.
https://doi.org/10.1007/s11357-024-01215-y |
3 |
2024 |
Imam Nurjaya, Erwin Arief, Nur Ahmad Tabri, Irawaty Djaharuddin, Bulkis Natsir, Sitti Nurisyah, Joko Hendarto, Ansariadi Ansariadi, Rasiha Rasiha, Moh. Anfasa Giffari Makkaraka. Durability of SARS-CoV-2 IgG response: a cross-sectional study in vaccinated healthcare workers using dried blood spot and multi-antigen profiling, Exploration of Immunology. 2024;
https://doi.org/10.37349/ei.2024.00166 |
4 |
2023 |
Amanda Izeli Portilho, Elizabeth De Gaspari. 2023;
https://doi.org/10.5772/intechopen.107908 |
5 |
2023 |
Hernan H. M. da Costa, Monica Bielavsky, Diego J. B. Orts, Sergio Araujo, Patrícia P. Adriani, Juliana S. Nogueira, Renato M. Astray, Ramendra P. Pandey, Marcelo Lancellotti, Jair P. Cunha-Junior, Carlos R. Prudencio. Production of Recombinant Zika Virus Envelope Protein by Airlift Bioreactor as a New Subunit Vaccine Platform, International Journal of Molecular Sciences. 2023; 24: 13955.
https://doi.org/10.3390/ijms241813955 |
6 |
2022 |
Amanda Izeli Portilho, Gabrielle Gimenes Lima, Elizabeth De Gaspari. SARS-CoV-2 vaccines: Potential refinements through induction of mucosal and trained immunity, Clinics. 2022; 77: 100057100057.
https://doi.org/10.1016/j.clinsp.2022.100057 |
7 |
2022 |
Jonathon M. Monroe, Iana H. Haralambieva, Nathaniel D. Warner, Diane E. Grill, Huy Quang Quach, Richard B. Kennedy. Longitudinal antibody titer, avidity, and neutralizing responses after SARS-CoV-2 infection, Heliyon. 2022; 8: e11676e11676.
https://doi.org/10.1016/j.heliyon.2022.e11676 |
8 |
2024 |
Amanda Izeli Portilho, Hernan Hermes Monteiro da Costa, Marcia Grando Guereschi, Carlos Roberto Prudencio, Elizabeth De Gaspari.
Hybrid response to SARS-CoV-2 and
Neisseria meningitidis
C after an OMV-adjuvanted immunization in mice and their offspring
, Human Vaccines & Immunotherapeutics. 2024; 20: 2346963.
https://doi.org/10.1080/21645515.2024.2346963 |
9 |
2023 |
Etsuhisa Takahashi, Takako Sawabuchi, Tetsuya Homma, Yosuke Fukuda, Hironori Sagara, Takeshi Kinjo, Kaori Fujita, Shigeru Suga, Takashi Kimoto, Satoko Sakai, Keiko Kameda, Hiroshi Kido. Clinical Utility of SARS-CoV-2 Antibody Titer Multiplied by Binding Avidity of Receptor-Binding Domain (RBD) in Monitoring Protective Immunity and Clinical Severity, Viruses. 2023; 15: 1662.
https://doi.org/10.3390/v15081662 |
10 |
2023 |
Hernan H. M. da Costa, Diego J. B. Orts, Andrew D. Moura, Amaro N. Duarte-Neto, Cinthya S. Cirqueira, Rodrigo A. Réssio, Cristina T. Kanamura, Karen Miguita, Jerenice E. Ferreira, Raimunda T. M. Santos, Patricia P. Adriani, Jair P. Cunha-Junior, Renato M. Astray, Regina M. Catarino, Marcelo Lancelotti, Carlos R. Prudencio. RBD and Spike DNA-Based Immunization in Rabbits Elicited IgG Avidity Maturation and High Neutralizing Antibody Responses against SARS-CoV-2, Viruses. 2023; 15: 555.
https://doi.org/10.3390/v15020555 |